Healthcare Real Estate Platform
Healthcare Real Estate Platform
A consolidated platform fund targeting a 13.0%-17.0% net return range across institutional-quality assets.
Investment thesis
Diversified healthcare real estate platform investing in senior living and skilled nursing, medical office buildings leased to investment-grade health systems, life sciences and laboratory real estate in established biotech clusters, and neighborhood healthcare and wellness centers. Combines demographic-driven demand with long-duration leases and specialized tenant credit characteristics.
How the fund is governed
- Structured as a Delaware limited partnership with a fund-specific general partner
- Investment period equal to one-half of the fund term
- Economic terms calibrated to strategy risk and cash-flow durability
- Deployment governed by the firm investment committee
- Audited by PricewaterhouseCoopers LLP with counsel from LePore Law Group
Where this fund deploys
Predecessor vehicles
Following the 2026 platform consolidation, this fund integrates the following original SBC fund vehicles under a single platform mandate, concentrating capital in a scaled, institutional-quality fund.
Funds IV, XXI, XXVI, XLV
We size each fund to the durability of its cash flows, not the appetite of the moment. Concentration follows conviction, and conviction follows underwriting.Slate Blue Capital Investment Committee
Talk to our investor relations team
For fund materials, capital account information, and partnership inquiries, reach Slate Blue Capital directly.
Contact Investor Relations